Drug Bioanalysis Services - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512243776

Publication Date:

December 6, 2024

Pages:

109

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Bioanalytical services are provided to researchers by contract research organizations who have the resources, expertise, instrumentation, and technology to tackle the most complex programs across multiple modalities and therapeutic areas for clinical and preclinical bioanalysis.
The global market for Drug Bioanalysis Services was estimated to be worth US$ 1401 million in 2023 and is forecast to a readjusted size of US$ 1916.5 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Bioanalysis Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Drug Bioanalysis Services by region & country, by Type, and by Application.
The Drug Bioanalysis Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Bioanalysis Services.
麻豆原创 Segmentation
By Company
Intertek
SGS
Medicilon
PPD, Inc.
ICON Plc
Eurofins Scientific
Charles River Laboratories International
Impact Analytical
QPS
Frontage Laboratories
ACM Global Laboratories
Segment by Type:
Macro Molecular Drug Bioanalysis
Small Molecule Drug Bioanalysis
Segment by Application
Pharmaceutical Development Corporation
Hospital
Academic Research Institute
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drug Bioanalysis Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Drug Bioanalysis Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Drug Bioanalysis Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Drug Bioanalysis Services Product Introduction
1.2 Global Drug Bioanalysis Services 麻豆原创 Size Forecast
1.3 Drug Bioanalysis Services 麻豆原创 Trends & Drivers
1.3.1 Drug Bioanalysis Services Industry Trends
1.3.2 Drug Bioanalysis Services 麻豆原创 Drivers & Opportunity
1.3.3 Drug Bioanalysis Services 麻豆原创 Challenges
1.3.4 Drug Bioanalysis Services 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drug Bioanalysis Services Players Revenue Ranking (2023)
2.2 Global Drug Bioanalysis Services Revenue by Company (2019-2024)
2.3 Key Companies Drug Bioanalysis Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Drug Bioanalysis Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Drug Bioanalysis Services
2.6 Drug Bioanalysis Services 麻豆原创 Competitive Analysis
2.6.1 Drug Bioanalysis Services 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Drug Bioanalysis Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Bioanalysis Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Macro Molecular Drug Bioanalysis
3.1.2 Small Molecule Drug Bioanalysis
3.2 Global Drug Bioanalysis Services Sales Value by Type
3.2.1 Global Drug Bioanalysis Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Drug Bioanalysis Services Sales Value, by Type (2019-2030)
3.2.3 Global Drug Bioanalysis Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical Development Corporation
4.1.2 Hospital
4.1.3 Academic Research Institute
4.1.4 Others
4.2 Global Drug Bioanalysis Services Sales Value by Application
4.2.1 Global Drug Bioanalysis Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Drug Bioanalysis Services Sales Value, by Application (2019-2030)
4.2.3 Global Drug Bioanalysis Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Drug Bioanalysis Services Sales Value by Region
5.1.1 Global Drug Bioanalysis Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Drug Bioanalysis Services Sales Value by Region (2019-2024)
5.1.3 Global Drug Bioanalysis Services Sales Value by Region (2025-2030)
5.1.4 Global Drug Bioanalysis Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Drug Bioanalysis Services Sales Value, 2019-2030
5.2.2 North America Drug Bioanalysis Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Drug Bioanalysis Services Sales Value, 2019-2030
5.3.2 Europe Drug Bioanalysis Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Drug Bioanalysis Services Sales Value, 2019-2030
5.4.2 Asia Pacific Drug Bioanalysis Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Drug Bioanalysis Services Sales Value, 2019-2030
5.5.2 South America Drug Bioanalysis Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Drug Bioanalysis Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Drug Bioanalysis Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drug Bioanalysis Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Drug Bioanalysis Services Sales Value
6.3 United States
6.3.1 United States Drug Bioanalysis Services Sales Value, 2019-2030
6.3.2 United States Drug Bioanalysis Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Drug Bioanalysis Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drug Bioanalysis Services Sales Value, 2019-2030
6.4.2 Europe Drug Bioanalysis Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Drug Bioanalysis Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Drug Bioanalysis Services Sales Value, 2019-2030
6.5.2 China Drug Bioanalysis Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Drug Bioanalysis Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Drug Bioanalysis Services Sales Value, 2019-2030
6.6.2 Japan Drug Bioanalysis Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Drug Bioanalysis Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Drug Bioanalysis Services Sales Value, 2019-2030
6.7.2 South Korea Drug Bioanalysis Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Drug Bioanalysis Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Drug Bioanalysis Services Sales Value, 2019-2030
6.8.2 Southeast Asia Drug Bioanalysis Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Drug Bioanalysis Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Drug Bioanalysis Services Sales Value, 2019-2030
6.9.2 India Drug Bioanalysis Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Drug Bioanalysis Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Intertek
7.1.1 Intertek Profile
7.1.2 Intertek Main Business
7.1.3 Intertek Drug Bioanalysis Services Products, Services and Solutions
7.1.4 Intertek Drug Bioanalysis Services Revenue (US$ Million) & (2019-2024)
7.1.5 Intertek Recent Developments
7.2 SGS
7.2.1 SGS Profile
7.2.2 SGS Main Business
7.2.3 SGS Drug Bioanalysis Services Products, Services and Solutions
7.2.4 SGS Drug Bioanalysis Services Revenue (US$ Million) & (2019-2024)
7.2.5 SGS Recent Developments
7.3 Medicilon
7.3.1 Medicilon Profile
7.3.2 Medicilon Main Business
7.3.3 Medicilon Drug Bioanalysis Services Products, Services and Solutions
7.3.4 Medicilon Drug Bioanalysis Services Revenue (US$ Million) & (2019-2024)
7.3.5 PPD, Inc. Recent Developments
7.4 PPD, Inc.
7.4.1 PPD, Inc. Profile
7.4.2 PPD, Inc. Main Business
7.4.3 PPD, Inc. Drug Bioanalysis Services Products, Services and Solutions
7.4.4 PPD, Inc. Drug Bioanalysis Services Revenue (US$ Million) & (2019-2024)
7.4.5 PPD, Inc. Recent Developments
7.5 ICON Plc
7.5.1 ICON Plc Profile
7.5.2 ICON Plc Main Business
7.5.3 ICON Plc Drug Bioanalysis Services Products, Services and Solutions
7.5.4 ICON Plc Drug Bioanalysis Services Revenue (US$ Million) & (2019-2024)
7.5.5 ICON Plc Recent Developments
7.6 Eurofins Scientific
7.6.1 Eurofins Scientific Profile
7.6.2 Eurofins Scientific Main Business
7.6.3 Eurofins Scientific Drug Bioanalysis Services Products, Services and Solutions
7.6.4 Eurofins Scientific Drug Bioanalysis Services Revenue (US$ Million) & (2019-2024)
7.6.5 Eurofins Scientific Recent Developments
7.7 Charles River Laboratories International
7.7.1 Charles River Laboratories International Profile
7.7.2 Charles River Laboratories International Main Business
7.7.3 Charles River Laboratories International Drug Bioanalysis Services Products, Services and Solutions
7.7.4 Charles River Laboratories International Drug Bioanalysis Services Revenue (US$ Million) & (2019-2024)
7.7.5 Charles River Laboratories International Recent Developments
7.8 Impact Analytical
7.8.1 Impact Analytical Profile
7.8.2 Impact Analytical Main Business
7.8.3 Impact Analytical Drug Bioanalysis Services Products, Services and Solutions
7.8.4 Impact Analytical Drug Bioanalysis Services Revenue (US$ Million) & (2019-2024)
7.8.5 Impact Analytical Recent Developments
7.9 QPS
7.9.1 QPS Profile
7.9.2 QPS Main Business
7.9.3 QPS Drug Bioanalysis Services Products, Services and Solutions
7.9.4 QPS Drug Bioanalysis Services Revenue (US$ Million) & (2019-2024)
7.9.5 QPS Recent Developments
7.10 Frontage Laboratories
7.10.1 Frontage Laboratories Profile
7.10.2 Frontage Laboratories Main Business
7.10.3 Frontage Laboratories Drug Bioanalysis Services Products, Services and Solutions
7.10.4 Frontage Laboratories Drug Bioanalysis Services Revenue (US$ Million) & (2019-2024)
7.10.5 Frontage Laboratories Recent Developments
7.11 ACM Global Laboratories
7.11.1 ACM Global Laboratories Profile
7.11.2 ACM Global Laboratories Main Business
7.11.3 ACM Global Laboratories Drug Bioanalysis Services Products, Services and Solutions
7.11.4 ACM Global Laboratories Drug Bioanalysis Services Revenue (US$ Million) & (2019-2024)
7.11.5 ACM Global Laboratories Recent Developments
8 Industry Chain Analysis
8.1 Drug Bioanalysis Services Industrial Chain
8.2 Drug Bioanalysis Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drug Bioanalysis Services Sales Model
8.5.2 Sales Channel
8.5.3 Drug Bioanalysis Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Intertek
SGS
Medicilon
PPD, Inc.
ICON Plc
Eurofins Scientific
Charles River Laboratories International
Impact Analytical
QPS
Frontage Laboratories
ACM Global Laboratories

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.